Remarkably, the results consistently revealed that ATM can serve as an independent prognostic factor for predicting the prognosis of melanoma patients, surpassing other factors such as age, gender, tissue location, mutation status, and stage (Figs. 1h and S4b). This evidence concerns the gene ATM and melanoma.